Securities Civil Remedies Health

Read need-to-know updates, commentary, and analysis on Securities issues written by leading professionals.
News & Analysis as of

Merck Resolves Investors’ Class Action Lawsuit Related To Vioxx

In 2004, Merck pulled its painkiller, Vioxx, from the market after a study linked the drug to increased risks for heart attack and strokes. On Friday, January 15, 2016, Merck announced that it had agreed to pay $830 million...more

Corporate and Financial Weekly Digest - May 21, 2010

In This Issue: *SEC/CORPORATE ..SEC Publishes Report from Forum on Small Business Capital Formation *FINANCIAL MARKETS ..CFTC-SEC Committee on Emerging Regulatory Issues to Meet *LITIGATION ..Court Affirms...more

The IRS Whistleblower Program: Updated Summary for Lawyers with Potential Tax Whistleblower Claims

A detailed description of the country's major "whistleblower" law, the False Claims Act and its "qui tam" provisions, which allow private citizens to report fraud against the government and share in the government's recovery...more

3 Results
|
View per page
Page: of 1

Follow Securities Updates on:

JD Supra Readers' Choice 2016 Awards

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×